The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
MIS-C Data and Reporting
This page is subject to change as a result of the end of the Public Health Emergency Order on 5/11/2023. Data will be updated as usual the week of 5/8/2023, and changes will go into effect the week of 5/15/2023. Anticipated changes are described below.
Publishing MIS-C surveillance has provided awareness of the condition and severe COVID outcomes for the public and providers. This surveillance will continue; however, this page will no longer be updated after 5/11/2023. Providers can access MIS-C resources here MIS-C Children (michigan.gov).
What is MIS-C?
“Multisystem Inflammatory Syndrome in Children (MIS-C) is a delayed hyperinflammatory condition in children and adolescents that occurs 2-6 weeks after SARS-CoV-2 infection. Children with MIS-C typically present with fever and various other symptoms, including abdominal (gut) pain, bloodshot eyes, diarrhea, dizziness, skin rash or vomiting. Not all children have the same symptoms. MIS-C can be serious, but most children who are diagnosed get better with medical care.
Health care providers and local health departments are asked to maintain a high degree of suspicion for MIS-C in pediatric and adolescent patients presenting with symptoms similar to Kawasaki Disease or ill individuals who have been previously exposed to COVID-19 with signs and symptoms. Patients have presented with fever, shock, multiorgan (cardiac, gastrointestinal, hematologic and dermatologic) involvement, and elevated inflammatory markers.”
Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C)
|# Cases Confirmed and Reported to CDC*||329|
|MIS-C associated Deaths||5 or fewer|
|Cases admitted to ICU||201 (61.1%)|
|Onset Date Range||4/14/20 to 4/21/2023|
|Age Range||0-20 years|
*Meets CDC Case Definition(s)
Current (2023) Definition: https://www.cdc.gov/mis/mis-c/hcp_cstecdc/index.html
** 2020 Definition only applies for cases with illness onsets prior to Jan 1, 2023
|<1 yrs||14||4.3%||Black/African American||112||34.1%|
|5-11 yrs||154||46.8%||All Others / Unknown||57||17.3%|
|Male||203||61.7%||Not Hispanic or Latino||244||74.2%|
|Female||126||38.3%||Hispanic or Latino||28||8.5%|
Red shading indicates the expected reporting lag for new cases. Cases with onset dates in this time period may not have been detected or reported yet.
- MIS-C Fast Fact Sheet
- Additional information on laboratory testing, other evaluations and treatment are available at CDC's MIS-C webpage: